Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Neurology, Neurosurgery, and Psychiatry 2003;74:495-497; doi:10.1136/jnnp.74.4.495
Copyright © 2003 by the BMJ Publishing Group Ltd.
Journal of Neurology Neurosurgery and Psychiatry 2003;74:495-497
© 2003 BMJ Publishing Group

SHORT REPORT

ß endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis

M Gironi1, R Furlan1, M Rovaris1, G Comi1, M Filippi1, A E Panerai2 and P Sacerdote2

1 Department of Neuroscience, San Raffaele Hospital, Milan, Italy
2 Department of Pharmacology, University of Milan, Milan, Italy

Correspondence to:
Correspondence to:
Dr M Gironi, San Raffaele, DIMER, Via Olgettina 48, 20132, Milan, Italy;
mgironi{at}dongnocchi.it

ABSTRACT

The possible link between the opioid peptide ß endorphin and the heterogeneity of the clinical course of multiple sclerosis (MS) was investigated. Peripheral blood mononuclear cells (PBMC) concentrations of ß endorphin were measured in 50 patients in different phases of MS. Thirty nine patients also underwent post-contrast magnetic resonance imaging of the brain. Among MS forms, the highest ß endorphin concentrations were found in PBMC from patients with relapsing remitting MS and the lowest in patients with the progressive forms. Average ß endorphin concentrations were lower, although not significantly, in patients with than in those without magnetic resonance imaging enhanced lesions. These data suggest that ß endorphin may have a role in the downregulation of the inflammatory process.

Keywords: ß endorphin; multiple sclerosis; immunomodulation

Abbreviations: MS, multiple sclerosis; PBMC, peripheral blood mononuclear cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Gironi, M, Martinelli-Boneschi, F, Sacerdote, P, Solaro, C, Zaffaroni, M, Cavarretta, R, Moiola, L, Bucello, S, Radaelli, M, Pilato, V, Rodegher, M., Cursi, M, Franchi, S, Martinelli, V, Nemni, R, Comi, G, Martino, G (2008). A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler 14: 1076-1083 [Abstract]  

eLetters:

Read all eLetters

Does MS-related plasma beta-endorphin vary in circadian manner?
J. Christopher Sullivan
JNNP Online, 19 Nov 2003 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs

Neurology and neurosurgery jobs